Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chen-Yu Hu
RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-Ron ADC Zt/G4-Mmae
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Autoinhibition of the Ron Receptor Tyrosine Kinase by the Juxtamembrane Domain
Cell Communication and Signaling
Biochemistry
Cell Biology
Molecular Biology
Tyrosine Kinase Receptor RON Functions Downstream of the Erythropoietin Receptor to Induce Expansion of Erythroid Progenitors
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The RON Receptor Tyrosine Kinase Regulates IFN- Production and Responses in Innate Immunity
Journal of Immunology
Allergy
Immunology
Role of Macrophage-Stimulating Protein and Its Receptor, RON Tyrosine Kinase, in Ciliary Motility.
Journal of Clinical Investigation
Medicine
Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
ICAM-1 as a Molecular Target for Triple Negative Breast Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer
Genes and Cancer
Cancer Research
Genetics
Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment
Oncotarget
Oncology
7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy
Pathology
Forensic Medicine
Pathology